Newstrail.com

$39.06 Billions Bioelectric Medicine Market Growing at CAGR of 7.3% over 2020-2030 Driven by Rising Acceptance of Bioelectric Medicines

Bioelectric Medicine Market

Highlighted with 106 tables and 76 figures, this 201-page report “Global Bioelectric Medicine Market 2020-2030 by Product Type (Implantable, Non-invasive), End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioelectric medicine market and all its sub-segments through extensively detailed classifications.

Bioelectric medicines, also known as electroceuticals, are medical devices that are used to restore health in patients. Bioelectric medicines function through neurostimulation and modulation of the nervous systems through electrical impulses. Global bioelectric medicine market will reach $39.06 billion by 2030, growing by a revised CAGR of 7.3% over 2020-2030 driven by growing geriatric population and rising acceptance of bioelectric medicines. The growth of bioelectric medicine market is driven by the increasing acceptance of electrotherapy in medical treatment and increasing demand for regenerative solutions for musculoskeletal injuries & degenerative joint diseases

The bioelectric medicine market is segmented based on product type, application, and geography into 4 major segments: mouth hydration products, face scrubs and cleansers, pulse rate trackers and pulse rate health bands. The mouth hydrating products segment is expected to account for the largest share in the global bioelectric medicine market in 2017 (North America), over the projection period. Face scrubs and cleansers are expected to register high growth during the research period owing to increasing awareness regarding benefits of facial cleansing etc.

Request Research Sample with Latest Industry Insights (200+ Pages Report): https://altusmarketresearch.com/reports/sample/29716

The bioelectric medicine market is the fastest growing segment of the energy medicine industry. Increasing awareness, government regulations, and increasing demand for naturally derived therapies have driven this segment to be one of the most promising markets.

The global bioelectric medicine market is expected to register significant growth during the forecast period of 2020, as the technologies are gaining acceptance in various applications such as novel diagnostic tools; various technological advancements; growing investor interest and developments in its industries in regions such as India and China.

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate/forecast from 2020 till 2030 with 2019 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Bioelectric medicine market Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioelectric medicine market in every aspect of the classification from perspectives of Product Type, End User, and Region.

Based on Product Type, the global bioelectric medicine market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Implantable Bioelectric Medicine
o Cardiac Pacemaker
o Implantable Cardioverter Defibrillators (ICD)
o Spinal Cord Stimulators (split into Chronic Pain, Failed Back Syndrome (FBSS), Ischemia by application)
o Cochlear Implants
o Deep Brain Stimulators (split into Parkinson’s Disease, Tremor, Depression, Other Deep Brain Stimulation Applications by application)
o Vagus Nerve Stimulators
o Sacral Nerve Stimulators (split into Urinary Incontinence and Fecal Incontinence by application)
o Retinal Implants
o Other Implantable Bioelectric Medicines
• Non-invasive Bioelectric Medicine
o Transcutaneous Electrical Nerve Stimulators
o Transcranial Magnetic Stimulation (TMS)
o Pulsed Electromagnetic Field Therapy
o Other Non-invasive Bioelectric Medicines

Based on End User, the global bioelectric medicine market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.

• Hospitals and Clinics
• Research Institutes
• Individual Users

Specifically, potential risks associated with investing in global bioelectric medicine market are assayed quantitatively and qualitatively through AMR’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players:

Abbott Laboratories
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Cochlear Limited
electroCore, Inc.
Inspire Medical Systems, Inc.
LivaNova PLC
Medtronic PLC
NeuroMetrix, Inc
Nevro Corp.
Nuvectra Corporation
OMRON CORPORATION
Pixium Vision
Second Sight Medical Products Inc
SetPoint Medical
Sonova Holding AG
St. Jude Medical, Inc.
Stimwave LLC